EHC — Encompass Health Corporation stock price, charts and financials

QT57Encompass Health Corporation

Encompass Health Corporation (NYSE: EHC) is a Healthcare company in the Medical - Care Facilities industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
110.50
-1.97-1.75%
EHCQT57Encompass Health Corporation·NYSE
110.50-1.75%
Earnings
Down 1.8% — Reported earnings — EPS beat by 7%, revenue beat by 1%.
High confidence
TA
Loading chart...
Screen all →
Snapshot
Index-P/E18.45EPS (ttm)5.99Insider Own1.82%Shs Outstand99.20MPerf Week-4.77%
Market Cap10.96BForward P/E16.90EPS next Y6.54Insider Trans-10.70%Shs Float97.92MPerf Month3.28%
Enterprise Value13.55BPEG1.65EPS next Q-Inst Own-Short Float4.00%Perf Quarter3.62%
Income610.00MP/S1.81EPS this Y0.25%Inst Trans-Short Ratio3.90Perf Half Y17.77%
Sales6.07BP/B3.26EPS next Y8.86%ROA8.33%Short Interest3.92MPerf YTD4.11%
Book/sh33.94P/C54.54EPS next 5Y11.19%ROE25.35%52W High128.00 -13.67%Perf Year1.82%
Cash/sh2.03P/FCF23.73EPS past 3/5Y27.07% 14.22%ROIC13.26%52W Low92.77 19.11%Perf 3Y67.25%
Dividend Est.0.84 (0.76%)EV/EBITDA9.27Sales past 3/5Y10.92% 10.73%Gross Margin58.82%Volatility2.34% 2.49%Perf 5Y71.37%
Dividend TTM0.76 (0.69%)EV/Sales2.23EPS Y/Y TTM34.30%Oper. Margin17.93%ATR (14)3.05Perf 10Y239.27%
Dividend Ex-DateOct 01, 2026Quick Ratio1.17Sales Y/Y TTM12.94%Profit Margin10.04%RSI (14)51.74Recom2.19
Dividend Gr. 3/5Y-4.46% -4.71%Current Ratio1.17EPS Q/Q16.79%SMA20-1.03%Beta0.74Target Price146.00
Payout12.05%Debt/Eq0.83Sales Q/Q9.07%SMA504.11%Rel Volume0.99Prev Close112.47
Employees42,300LT Debt/Eq0.81EarningsAug 05SMA2003.29%Avg Volume952.30KPrice110.50
IPO DateSep 24, 1986Option/ShortYes / YesEPS/Sales Surpr.7.09% 1.21%Net Debt/EBITDA1.80Volume940,567Change-1.75%
Analyst Ratings
DateActionAnalystRatingTarget
May-22-26ReiteratedLeerink Partners$152
May-05-26ReiteratedBarclaysOverweight$153$140
Feb-06-26ReiteratedBarclaysOverweight$150$153
Oct-30-25ReiteratedBarclaysOverweight$101$150
Oct-02-25ReiteratedUBSBuy$110$150
Aug-14-25ReiteratedTruist SecuritiesBuy$140
Apr-28-25ReiteratedRBC CapitalOutperform$105$125
Sep-26-24ReiteratedRBC CapitalOutperform$95$105
Sep-25-24ReiteratedUBSBuy$110
May-22-24ReiteratedRBC CapitalOutperform$85$95
Latest News
Aug-04-26
Aug-03-26
Jul-26-26
Jul-23-26
Jul-17-26
Jul-09-26
Jul-08-26
Jun-30-26
Jun-29-26
Jun-24-26
Jun-17-26
Jun-15-26
Jun-11-26
Jun-10-26
Company

Encompass Health Corporation delivers a range of post-acute healthcare services across the United States, offered both in dedicated facilities and directly within patients' homes. The company's operations are divided into two primary divisions: Inpatient Rehabilitation, and Home Health and Hospice. Its Inpatient Rehabilitation division specializes in providing focused recovery treatment, available on an inpatient or outpatient basis. This care is designed for individuals recuperating from significant health challenges such as strokes, neurological disorders, cardiac and pulmonary issues, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment primarily serves the Southeast and Texas regions. Within this segment, home health services encompass a variety of Medicare-certified care options for adult patients, including skilled nursing, medical social work, home health aide assistance, and various therapies like physical, occupational, and speech therapy. Hospice services, on the other hand, provide in-home comfort and support for terminally ill patients and their families. As of June 1, 2022, Encompass Health maintained a substantial network, managing 149 hospitals, 252 home health locations, and 99 hospice locations spread across 42 U.S. states and Puerto Rico. The company, which established its roots in 1983 and is headquartered in Birmingham, Alabama, was formerly known as HealthSouth Corporation until its name change to Encompass Health Corporation in January 2018.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue6,0685,9355,3734,8014,3494,0153,5664,6054,277
Cost of Goods Sold Incl. D&A2,4992543,1402,8182,5952,312171168159
Gross Profit3,5695,6812,2331,9831,7531,7033,3954,4374,119
Selling, General and Administrative Excl. Other1,0723,4112672582092292,1172,9022,652
Research and Development
000000000
Other Operating Expense1,4091,2171,10209148151,2781,5351,467
Operating Income1,0881,0538651,7256306590693682
Interest Expense123123137144176164184160147
Unusual Expense
Non-Operating Income (Expense)392323-974-41053730-41
Net Income Before Taxes1,004953750607451505353562493
Income Taxes20719315013210010275116119
Consolidated Net Income610566456352271412284359292
Net Income From Continuing Operations795760599475351403278446374
Net Income610566456352271412284359292
EPS (Recurring)6.085.624.533.542.724.152.873.652.99
EPS (Basic, Before Extraordinaries)6.085.624.533.542.724.152.873.652.99
EPS (Diluted)5.995.544.463.472.704.112.853.612.93
EBITDA1,4621,4041,1871,006870889740941840
Other After Tax Adjustments
Stock Option Compensation Expense
Price To Earnings Ratio18.4519.1620.7119.2322.1512.6323.0715.2616.74
Price To Sales Ratio1.801.811.721.391.361.281.831.171.12
Gross Margin58.8295.7241.5641.3040.3142.4295.2096.3596.31
Operating Margin17.9317.7416.1035.9314.4916.410.0015.0515.95
Net Margin10.059.548.497.336.2310.267.967.806.83
Shares Outstanding991011001009999999898
Market Capitalization10,94010,7209,2356,6725,9215,1376,5095,3984,808
Operating Lease Expense
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$132.18$121.34$110.50$99.67$88.83 Close Price0.00M4.26M8.52M12.79M17.05MUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
COLTHARP DOUGLAS EEVP & Chief Financial OfficerMay 15 '26Sale106.8327,6942,958,55069,377May 18
COLTHARP DOUGLAS EEVP & Chief Financial OfficerMay 15 '26Option Exercise32.9427,694912,24097,071May 18
Tuer Patrick WilliamEVP, Chief Operating OfficerMay 11 '26Sale104.5668271,31024,755May 12
Fay EdmundSr. Vice Pres. and TreasurerMar 09 '26Sale107.0011,9371,277,25989,325Mar 10
Tarr Mark JPresident & CEOFeb 11 '26Sale111.64150,00016,746,689377,070Feb 12
Tuer Patrick WilliamEVP, Chief Operating OfficerFeb 10 '26Sale107.622,804301,76616,042Feb 10
Tuer Patrick WilliamEVP, Chief Operating OfficerAug 27 '25Sale123.591,020126,06218,846Aug 27
Tarr Mark JPresident & CEOMay 20 '25Option Exercise40.10118,3844,747,112645,454May 20
Tarr Mark JPresident & CEOMay 20 '25Sale121.53118,38414,387,152527,070May 20
Charbonneau Elissa JoyChief Medical OfficerMay 06 '25Sale116.614,279498,97411,958May 07
Darby John PatrickEVP, Gen Counsel & SecretaryApr 29 '25Option Exercise35.0610,000350,60089,710Apr 30
Darby John PatrickEVP, Gen Counsel & SecretaryApr 29 '25Sale114.7910,0001,147,90079,710Apr 30
COLTHARP DOUGLAS EEVP & Chief Financial OfficerApr 29 '25Option Exercise31.5143,5751,372,990103,910Apr 30
COLTHARP DOUGLAS EEVP & Chief Financial OfficerApr 29 '25Sale115.1543,5755,017,53760,335Apr 30
Price Andrew LChief Accounting OfficerFeb 13 '25Sale98.295,042495,57869,164Feb 13
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.